Compound Chinese medicinal preparation for treating ulcerative colitis and preparation method thereof

Abstract

The invention relates to a compound Chinese medicinal preparation for treating ulcerative colitis. The compound Chinese medicinal preparation comprises the following Chinese medicinal raw materials in weight by percentage: 8-12 percent of codonopsis pilosula, 16-24 percent of astragalus root, 13-17 percent of tuckahoe, 8-12 percent of bighead atractylodes rhizome, 8-12 percent of costus root, 8-12 percent of white paeony root, 5-7 percent of coptis root, 13-17 percent of Chinese pulsatilla root and 5-7 percent of liquoric root. A preparation method of the compound Chinese medicinal preparation comprises the following steps of: cleaning the 9 medicinal materials; mixing in proportion; adding water in an amount which is 5-7 times the total weight of the medicinal materials or ethanol in an amount which is 70 percent of the volume ratio to decoct for 3 times, 1 hour each time; combining decoction for 3 times; filtering; and concentrating to obtain liquid extract with specific gravity of 1.17 at the temperature of 60 DEG C. By adopting the conventional reparation process, the preparation can be prepared into any one pharmaceutically said formulation, such as tablets, capsules, granules, dripping pills, oral liquid, pills, syrup, dispersible tablets and effervescent tablets. The compound Chinese medicinal preparation for treating the depression prepared by the invention has the advantages of obvious curative effect and no adverse effect, and can be applied to treatment of the ulcerative colitis in a large range.

Description

technical field [0001] The invention relates to a traditional Chinese medicine compound preparation for treating ulcerative colitis and a preparation method thereof, belonging to the field of traditional Chinese medicine preparations. Background technique [0002] Ulcerative colitis (Ulcerative Colitis, UC) is a chronic nonspecific inflammatory disease of the colon with unknown etiology. Mainly limited to the large intestine mucosa and submucosa, with abdominal pain, diarrhea, mucus, pus and blood in the stool, tenesmus, etc. as the main symptoms. With the continuous improvement of living standards and changes in diet structure and living habits, the incidence rate is on the rise year by year. It is difficult to cure and easy to relapse after recovery, and even has a certain relationship with the incidence of colon cancer. This disease belongs to the categories of "diarrhea", "long-term dysentery", "rest dysentery" and "intestinal wind" in traditional Chinese medicine. [...

AI Technical Summary

Problems solved by technology

[0003] At present, most of the drugs used to treat ulcerative colitis are immunosuppressants or drugs related to immune function, but they have the disadvantages of many adverse reactions, single administration method, and insignificant curative effect.